StockVS

Solesence, Inc. (SLSN) 株式分析

生活必需品

Solesence, Inc.

$1.28

+$0.03 (+2.81%)

最終更新日: 2026年5月26日

株価推移

分析

企業概要

Solesence, Inc. operates as a science-driven enterprise providing engineered materials, formulation development, and commercial manufacturing services within the United States, specifically focusing on the supply of surface-engineered zinc oxide and titanium dioxide ingredients. The company functions within the Consumer Defensive sector under the Household & Personal Products industry classification, indicating its role in supplying essential components for daily consumer goods where demand remains relatively stable regardless of economic cycles. With a market capitalization of $92.53M and an annual revenue of $62.06M over the trailing twelve months, Solesence, Inc. employs a workforce of 115 individuals to support its operational activities. These valuation and revenue figures suggest the company maintains a small-cap profile, positioning it as a specialized niche player rather than a dominant market leader, which often implies higher volatility and sensitivity to specific supply chain dynamics within the personal care and industrial material sectors.

財務健全性

Solesence, Inc. reported a trailing twelve-month revenue of $62.06M with a corresponding net income of $1.79M and an EBITDA of $2.47M, revealing a significant gap between top-line generation and bottom-line profitability that points to a cost structure heavily impacted by operating expenses and potentially non-recurring items. The company's free cash flow stands at $-11,546,625, indicating a substantial cash outflow relative to earnings, which suggests limited financial flexibility for capital expenditure or dividend distribution without external financing. Analyzing the profit margins, the firm maintains a gross margin of 25.9%, an operating margin of 1.5%, and a profit margin of 2.9%, where the low operating and profit margins indicate that after accounting for overhead and administrative costs, the company retains a very thin slice of revenue as actual profit. Regarding liquidity and leverage, the company holds $1.29M in cash against $24.32M in debt, resulting in a debt-to-equity ratio of 137.91, which characterizes the balance sheet as highly leveraged and potentially vulnerable to interest rate hikes or a downturn in operating cash flows. The current ratio is calculated at 2.07, suggesting that the company possesses more than double the current assets needed to cover its short-term liabilities, indicating a comfortable position regarding immediate solvency despite the high debt load. Furthermore, the return on equity is 11.0% while the return on assets is 2.0%, revealing that while the company generates significant returns for shareholders relative to equity invested, its overall efficiency in utilizing total assets to generate profit is relatively low, likely due to the high leverage amplifying the equity return.

バリュエーション評価

The valuation metrics for Solesence, Inc. show a trailing P/E ratio of 65.50 with a forward P/E marked as N/A, implying that analysts lack sufficient consensus on future earnings projections to calculate a forward multiple, which often reflects uncertainty about the trajectory of earnings growth for smaller or less predictable companies. The price-to-book ratio stands at 5.24, indicating that the market values the company's equity at more than five times its book value, suggesting a significant market premium that investors are willing to pay for the company's intangible assets, proprietary technology, or growth potential beyond its tangible net worth. Alternative valuation metrics such as the price-to-sales ratio of 1.49 and an EV/EBITDA of 46.80 provide additional context, showing that the market is pricing in substantial future growth expectations relative to current sales and earnings power. The stock has exhibited extreme price volatility over the past year, trading between a 52-week low of $0.78 and a 52-week high of $16.56, meaning the current valuation sits in a wide range that reflects significant investor sentiment swings rather than steady fundamental progression. Additionally, the beta value of 1.17 indicates that the stock is more volatile than the broader market, moving approximately 17% more than the benchmark index, which is consistent with the high P/E and low profit margins observed in the financial health section.

Growth & Income

Solesence, Inc. experienced a year-over-year revenue growth of -0.7% while earnings growth is listed as N/A, suggesting that the company is currently in a contractionary phase where revenue is declining and earnings data is either negligible or insufficient to calculate a meaningful growth rate. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which implies that the firm reinvests its limited net income of $1.79M back into the business operations to fund its manufacturing services and material development rather than distributing cash to shareholders. This non-dividend profile is typical for companies with negative free cash flow and high debt obligations, as retaining earnings is necessary to manage the $24.32M in debt and cover the $11.5M in negative cash burn. Overall, the growth and income profile of Solesence, Inc. is characterized by declining revenue, a complete absence of dividend income, and a reliance on retained earnings to sustain operations within a highly leveraged financial structure.

同業他社比較

Solesence, Inc. (SLSN) は家庭用品・パーソナルケア業界で事業を展開しています。時価総額による最も近い同業他社との比較は以下の通りです:

企業名 ティッカー 時価総額 PER
Solesence, Inc. SLSN $90.41M 128.0
The Procter & Gamble Company PG $336.34B 21.1
Unilever PLC UL $123.97B 19.0
Colgate-Palmolive Company CL $71.90B 34.8

家庭用品・パーソナルケア業界の平均PERは29.9倍です。Solesence, Inc.のPERは128.0です。

この分析はAIによって生成されたものであり、情報提供のみを目的としています。投資アドバイスではありません。データは遅延または不正確な場合があります。投資判断を行う前に、必ずご自身で調査を行い、資格を持つファイナンシャルアドバイザーにご相談ください。

Solesence, Inc.について

Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.

企業説明は英語で表示されています。

ウェブサイトを見る →

主要指標

時価総額
$90.41M
PER
128.00
52週高値
$5.63
52週安値
$0.78
平均出来高
40.83K
ベータ
1.30

データはYahoo Financeよりyfinance経由で提供。毎日更新。

企業情報

取引所
NASDAQ
United States
従業員数
115